Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: A predictive analysis of optimized, patient-specific dwell times for the day period

Peritoneal Dialysis International

Volumn 33, Issue 6, 2013, Pages 646-654

  Akonur, Alp ^a   Guest, Steven ^b   Sloand, James A ^b   Leypoldt, John K ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Medical Products (Renal)   (United States)

Author keywords

Dry period; Individualized dwell time; Sodium removal; Therapy optimization; Ultrafiltration; Ultrafiltration efficiency

Indexed keywords

BETA 2 MICROGLOBULIN; ICODEXTRIN; SODIUM; UREA;

ARTICLE; BODY SURFACE; CARBOHYDRATE ABSORPTION; COMPARATIVE STUDY; COMPUTER MODEL; COMPUTER SIMULATION; HUMAN; MAJOR CLINICAL STUDY; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PRESCRIPTION; PRIORITY JOURNAL; ULTRAFILTRATION;

DRY PERIOD; INDIVIDUALIZED DWELL TIME; SODIUM REMOVAL; THERAPY OPTIMIZATION; ULTRAFILTRATION; ULTRAFILTRATION EFFICIENCY;

BETA 2-MICROGLOBULIN; BIOLOGICAL TRANSPORT; COMPUTER SIMULATION; DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; SODIUM; TIME FACTORS; ULTRAFILTRATION;

EID: 84890384970     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00261     Document Type: Article

References (44)

1. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16:1459-64.
2. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
3. Blake PG, Bargman JM, Brimble KS, Davison SN, Hirsch D, McCormick BB, et al. on behalf of the Canadian Society of Nephrology Work Group on Adequacy of Peritoneal Dialysis. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit Dial Int 2011; 31:218-39.
4. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
5. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl 2006; 70:S76-83.
6. Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17:271-8.
7. Krediet RT, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev nephrol 2010; 6:451-60.
8. Fried L. Higher membrane permeability predicts poorer survival. Perit Dial Int 1997; 17:387-9.
9. Wang T, Heimbürger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
10. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
11. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. on behalf of the EAPOS Group. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948-57.
12. Kircelli F, Asci G, Yilmaz M, Sevinc E, Demirci MS, Toz H, et al. The impact of strict volume control strategy on patient survival and technique failure in peritoneal dialysis patients. Blood Purif 2011; 32:30-7.
13. Prakash J, Singh KL, Shreeniwas S, Ghosh B, Singh TB. Non-infectious complications of continuous ambulatory peritoneal dialysis and their impact on technique survival. Indian J Nephrol 2011; 21:112-15.
14. Coester AM, Parikova A, Smit W, Struijk DG, Krediet RT. Mechanisms in ultrafiltration failure of long-term peritoneal dialysis patients. Port J Nephrol Hypertens 2008; 22:217-20.
15. Freida P, Galach M, Divino Filho JC, Werynski A, Lindholm B. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long dwell. Perit Dial Int 2007; 27:267-76.
16. Freida P, Issad B, Dratwa M, Lobbedez T, Wu L, Leypoldt JK, et al. A combined crystalloid and colloid PD solution as a glucose-sparing strategy for volume control in high-transport APD patients: a prospective multicenter study. Perit Dial Int 2009; 29:433-42.
17. Akonur A, Leypoldt JK. Three-pore model predictions of 24-hour therapy using bimodal solutions. Perit Dial Int 2011; 31:537-44.
18. Perez RA, Blake PG, McMurray S, Mupas L, Oreopoulos DG. What is the optimal frequency of cycling in automated peritoneal dialysis? Perit Dial Int 2000; 20:548-56.
19. Demetriou D, Habicht A, Schillinger M, Horl WH, Vychytil A. Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int 2006; 70:1649-55.
20. Davison SN, Jhangri JS, Jindal K, Pannu N. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis. Clin J Am Soc nephrol 2009; 4:1044-50.
21. Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int 2011; 31:450-8.
22. Fischbach M, Lahlou A, Eyer D, Desprez P, Geisert J. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual dialysis modality prescription in children. Perit Dial Int 1996; 16(Suppl 1):S557-60.
23. Durand PY, Freida P, Issad B, Chanliau J. How to reach optimal creatinine clearances in automated peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S167-70.
24. Gobin J, Fernando S, Santacroce S, Finkelstein FO. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. Blood Purif 2008; 26:279-83.
25. Sav T, Oymak O, Inanc MT, Dogan A, Tokgoz B, Utas C. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass on patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2009; 29:443-9.
26. Ballout A, Garcia-Lopez E, Struyven J, Marechal C, Goffin E. Double-dose icodextrin to increase ultrafiltration in PD patients with inadequate ultrafiltration. Perit Dial Int 2011; 31:91-4.
27. Mujais S, Vonesh E. Profiling of peritoneal ultrafiltration. Kidney Int Suppl 2002; 62:S17-22.
28. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
29. Vonesh EF, Story KO, O'Neill WT. A multinational clinical validation study of PD Adequest 2.0. PD Adequest International Study Group. Perit Dial Int 1999; 19:556-71.
30. Vonesh EF, Rippe B. Net fluid absorption under membrane transport models of peritoneal dialysis. Blood Purif 1992; 10:209-26.
31. Akonur A, Holmes CJ, Leypoldt JK. Ultrafiltration efficiency during automated peritoneal dialysis using glucose-based solutions. Adv Perit Dial 2008; 28:69-74.
32. Rodriguez-Carmona A, Fontán MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 2002; 22:705-13.
33. Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, et al. The effects of low sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009; 24:1609-17.
34. Fourtounas C, Hardalias A, Dousdampanis P, Papachristopoulos B, Savidaki E, Vlachojannis JG. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities. Adv Perit Dial 2008; 24:27-31.
35. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc nephrol 2003; 14:2338-44.
36. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. on behalf of the Icodextrin High Transporter Trial Group. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
37. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc nephrol 1994; 4:1820-6.
38. Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, et al. Recommended practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448-56.
39. Krediet RT, Douma CE, van Olden RW, Ho-dac-Pannakeet MM, Struijk DG. Augmenting solute clearance in peritoneal dialysis. Kidney Int 1998; 54:2218-25.
40. Durand PY, Balteau P, Chanliau J, Kessler M. Optimization of fill volumes in automated peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 2):S83-8.
41. Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc nephrol 1996; 7:198-207.
42. McCormick BB, Bargman JM. The implications of the ADEMEX Study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal. Curr opin nephrol Hypertens 2003; 12:581-5.
43. Li PK, Chow KM. Maximizing the success of peritoneal dialysis in high transporters. Perit Dial Int 2007; 27(Suppl 2):S148-52.
44. Selgas R, Bajo MA, Castro MJ, Sanchez-Tomero JA, Cirugeda A. Managing ultrafiltration failure by peritoneal resting. Perit Dial Int 2000; 20:595-7.